BR9305557A - Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém - Google Patents

Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém

Info

Publication number
BR9305557A
BR9305557A BR9305557A BR9305557A BR9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A
Authority
BR
Brazil
Prior art keywords
antibodies
rhesus
pharmaceutical composition
composition containing
human monoclonal
Prior art date
Application number
BR9305557A
Other languages
English (en)
Inventor
Roland Beliard
Ulf Bethke
Dominique Bourel
Ahmed Bouzidi
Herve Broly
Peter Byrne
Magali Houluigue
Michael Kloft
Detlef Rohm
Original Assignee
Aetsrn
Biotest Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9207893A external-priority patent/FR2692786B1/fr
Priority claimed from DE19924224357 external-priority patent/DE4224357C2/de
Application filed by Aetsrn, Biotest Pharma Gmbh filed Critical Aetsrn
Publication of BR9305557A publication Critical patent/BR9305557A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9305557A 1992-06-26 1993-06-22 Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém BR9305557A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9207893A FR2692786B1 (fr) 1992-06-26 1992-06-26 Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.
DE19924224357 DE4224357C2 (de) 1992-07-23 1992-07-23 Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper
PCT/EP1993/001591 WO1994000561A1 (en) 1992-06-26 1993-06-22 Human monoclonal anti-rhesus (d) antibodies and cell lines producing same

Publications (1)

Publication Number Publication Date
BR9305557A true BR9305557A (pt) 1997-03-25

Family

ID=25916870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305557A BR9305557A (pt) 1992-06-26 1993-06-22 Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém

Country Status (12)

Country Link
US (1) US5851524A (pt)
EP (1) EP0576093B1 (pt)
AT (1) ATE191006T1 (pt)
AU (1) AU678364B2 (pt)
BR (1) BR9305557A (pt)
CA (1) CA2116246A1 (pt)
DE (1) DE69328135D1 (pt)
FI (1) FI940811A (pt)
HU (1) HUT68624A (pt)
MX (1) MX9303839A (pt)
PL (1) PL302438A1 (pt)
WO (1) WO1994000561A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2858235B1 (fr) 2003-07-31 2006-02-17 Lab Francais Du Fractionnement Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
FR2861078B1 (fr) * 2003-10-16 2007-09-21 Lab Francais Du Fractionnement NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE
US8198415B2 (en) 2004-07-20 2012-06-12 Symphogen A/S Anti-rhesus D recombinant polyclonal antibody
DE602005016818D1 (de) 2004-07-20 2009-11-05 Symphogen As Verfahren zur charakterisierung einer polyklonalen zellinie
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
MX2009012786A (es) 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
CA2639003A1 (en) * 2008-08-20 2010-02-20 Canadian Blood Services Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
EP2379108B1 (en) 2008-12-22 2014-06-25 F. Hoffmann-La Roche AG Immunoglobulin purification
US20110059079A1 (en) * 2009-09-04 2011-03-10 Xoma Technology Ltd. Antibody Coformulations
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
CN106267405B (zh) * 2016-07-01 2019-02-19 翁炳焕 母胎血型不合溶血病治疗仪

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8906129D0 (en) * 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations

Also Published As

Publication number Publication date
MX9303839A (es) 1994-08-31
EP0576093A1 (en) 1993-12-29
CA2116246A1 (en) 1994-01-06
EP0576093B1 (en) 2000-03-22
US5851524A (en) 1998-12-22
WO1994000561A1 (en) 1994-01-06
HUT68624A (en) 1995-07-28
AU4419793A (en) 1994-01-24
AU678364B2 (en) 1997-05-29
DE69328135D1 (de) 2000-04-27
FI940811A0 (fi) 1994-02-21
HU9400862D0 (en) 1994-06-28
FI940811A (fi) 1994-02-21
ATE191006T1 (de) 2000-04-15
PL302438A1 (en) 1994-07-25

Similar Documents

Publication Publication Date Title
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
BR9305557A (pt) Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
GR3030141T3 (en) Diphtheria toxin receptor-binding region.
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
SI0865448T1 (en) Apoptosis induced by monoclonal antibody anti-her2
MX9805253A (es) Antagonistas del receptor de vitronectina.
ES2161751T3 (es) Anticuerpo monoclonal que se une especificamente al endotelio vascular tumoral y usos del mismo.
UA50708C2 (uk) Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382
ZA965235B (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
EP0538754A3 (en) Use of antibody-containing preparations for immunosuppression
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
HK1016017A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
EP0493446A4 (en) Treatment of autoimmune disease
DE69007799D1 (de) Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen.
ATE189122T1 (de) Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
GB9224888D0 (en) Monoclonal antibody
DE59309133D1 (de) Granulozytenbindende Antikörperkonstrukte, ihre Herstellung und Verwendung
HUP9700364A2 (hu) Fluidágyas reaktor hulladék hőkezelésére
WO1991010722A3 (en) Chimeric immunoglobulin for cd4 receptors
IT1254705B (it) Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante
DE69534740D1 (en) Analoge des thymosin alpha 1
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal